Advertisement
U.S. Markets closed

VBI Vaccines Inc. (VBIV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.6026+0.0226 (+3.90%)
At close: 04:00PM EDT
0.5698 -0.03 (-5.44%)
After hours: 06:56PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close0.5800
Open0.6100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5900 - 0.6130
52 Week Range0.4500 - 9.6000
Volume125,023
Avg. Volume123,345
Market Cap14.274M
Beta (5Y Monthly)1.91
PE Ratio (TTM)N/A
EPS (TTM)-9.7900
Earnings DateApr 01, 2024 - Apr 05, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for VBIV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • VBI Vaccines, Inc.
    Technical Assessment: Neutral in the Intermediate-TermWas that a case of quarter-end buying by institutions? Over the last 50 minutes of the trading session on Wednesday, the S&P 500 (SPX) took off like a rocket, surging 30 points and finishing 0.9% higher on the day and at another all-time high. But the biggest winners on the day were small-caps, with the Russell 2000 (IWM) surging 2.2% and the S&P 600 (SML) spiking 2.4%. The IWM is breaking out of a more-than two-year base and closed at its highest level since December 2021.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more